Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence
Por:
Agra-Bermejo, R, Cordero, A, Veloso, P, Alvarez, D, Alvarez, B, Diaz, B, Rodriguez, L, Abou-Jokh, C, Alvarez, B, Gonzalez-Juanatey, J and Acuna, J
Publicada:
30 jun 2021
Resumen:
The benefit of complete revascularization in elderly patients with non-ST elevation myocardial infarction (NSTEMI), and multivessel disease remains debated (MVD). The aim of our study was to determine the current long-term prognostic benefit of complete revascularization in this population. A retrospective cohort study of 1722 consecutive elderly NSTEMI patients was performed. Among the study participants 30.4% (n = 524) were completed revascularizated and in 69.6% (n = 1198) culprit vessel only revascularization was performed. A propensity score analysis was performed and we divided the study population into two groups: complete revascularization (n = 500) and culprit vessel only revascularization (n = 500). The median follow-up was 45.7 months, the all cause mortality (44.5% vs 30.5%, p < 0.001) (HR 0.74 (0.57-0.97); p = 0.035) and cardiovascular mortality (32.6% vs 17.4%, p < 0.001) (HR = 0.67 (0.47-0.94); p = 0.021) were significantly lower in patients with complete revascularization. In our study, we observed a long-term benefit of complete revascularization in elderly NSTEMI and MVD patients. Elderly patients should also be managed according to current guidelines to improve their long-term prognosis.
Filiaciones:
Agra-Bermejo, R:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain
:
Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain
Clin Univ Hosp San Juan, Cardiol Dept, Alicante 00927, Spain
Veloso, P:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Alvarez, D:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Alvarez, B:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain
Diaz, B:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Rodriguez, L:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Abou-Jokh, C:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Alvarez, B:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain
Gonzalez-Juanatey, J:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain
Acuna, J:
Clin Univ Hosp Santiago de Compostela, Cardiol Dept, Santiago De Compostela 15706, Spain
Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain
gold
|